10:38 AM EDT, 09/24/2024 (MT Newswires) -- Aurinia Pharmaceuticals ( AUPH ) said Japan's Ministry of Health, Labor and Welfare approved voclosporin in combination with mycophenolate mofetil to treat lupus nephritis.

The approval is based on efficacy and safety data of voclosporin, which is available in the US under the brand name Lupkynis, Aurinia said Tuesday in a statement.

The company said its collaboration partner, Otsuka Pharmaceutical, filed the new drug application in Japan in November.

Price: 6.84, Change: -0.14, Percent Change: -2.02